Dashboard
Manage Tickers

DVADAVITA INC.

NYSE davita.com


$ 137.50 $ -0.42 (-0.3 %)    

Friday, 10-May-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 137.52
$ 138.84
$ 0.00 x 0
$ 0.00 x 0
$ 136.75 - $ 140.25
$ 71.51 - $ 145.04
743,556
na
12.45B
$ 0.85
$ 15.27
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-14-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 10-31-2022 09-30-2022 10-Q
8 08-01-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-11-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-12-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 02-22-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 02-23-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-01-2017 06-30-2017 10-Q
29 05-02-2017 03-31-2017 10-Q
30 02-24-2017 12-31-2016 10-K
31 11-02-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-05-2015 03-31-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-01-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

6-analysts-assess-davita-what-you-need-to-know
6 Analysts Assess DaVita: What You Need To...
05/06/2024 21:00:30

barclays-maintains-equal-weight-on-davita-raises-price-target-to-150
Barclays Maintains Equal-Weight on DaVita,...
05/06/2024 15:26:44

Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price target from $133 to $150.

davita-shares-are-trading-higher-after-the-company-reported-better-than-expected-q1-financial-results-revised-its-fy24-adjusted-eps-guidance
DaVITA shares are trading higher after the...
05/03/2024 12:25:58

davita-revises-fy24-adj-eps-outlook-from-870-980-to-900-980-est-901
DaVita Revises FY24 Adj EPS Outlook From $...
05/02/2024 20:37:24

davita-q1-2024-adj-eps-238-beats-195-estimate-sales-3071b-beat-3028b-estimate
DaVita Q1 2024 Adj EPS $2.38 Beats $1.95 E...
05/02/2024 20:07:14

DaVita (NYSE:DVA) reported quarterly Adj earnings of $2.38 per share which beat the analyst consensus estimate of $1.95 by 22.0...

the-american-diabetes-association-and-davita--announce-expansion-of-a-multi-year-collaboration-focused-on-advancing-chronic-disease-prevention-specifically-addressing-diabetes-and-chronic-kidney-disease
The American Diabetes Association And DaVi...
03/11/2024 20:44:23

Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National K...

barclays-initiates-coverage-on-davita-with-equal-weight-rating-announces-price-target-of-133
Barclays Initiates Coverage On DaVita with...
03/06/2024 21:09:17

Barclays analyst Sarah James initiates coverage on DaVita (NYSE:DVA) with a Equal-Weight rating and announces Price Target o...

why-are-dialysis-provider-stocks-trading-higher-on-tuesday
Why Are Dialysis Provider Stocks Trading H...
03/05/2024 20:21:24

Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with sema...

why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why SOPHiA GENETICS Shares Are Trading Low...
03/05/2024 18:11:47

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...

nio-reports-upbeat-earnings-joins-dave-v2x-riskified-and-other-big-stocks-moving-higher-on-tuesday
NIO Reports Upbeat Earnings, Joins Dave, V...
03/05/2024 15:56:57

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

davita-enters-into-agreement-to-expand-operations-in-brazil-and-colombia-enter-chile-and-ecuador-involving-four-separate-acquisitions-from-fresenius-medical-care-for-a-total-purchase-price-of-300m
DaVita Enters Into Agreement To Expand Ope...
03/05/2024 14:07:58

Expansion would make DaVita the largest dialysis services provider in Latin America

dialysis-player-fresenius-medicals-q4-sales-hold-steady-details
Dialysis Player Fresenius Medical's Q4 Sal...
02/20/2024 18:17:43

Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024.

davita-stock-a-deep-dive-into-analyst-perspectives-4-ratings
DaVita Stock: A Deep Dive Into Analyst Per...
02/20/2024 15:00:49

charles-river-laboratories-international-posts-upbeat-results-joins-robinhood-zillow-tower-semiconductor-and-other-big-stocks-moving-higher-on-wednesday
Charles River Laboratories International P...
02/14/2024 15:36:38

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.

truist-securities-maintains-hold-on-davita-raises-price-target-to-130
Truist Securities Maintains Hold on DaVita...
02/14/2024 13:15:36

Truist Securities analyst David Macdonald maintains DaVita (NYSE:DVA) with a Hold and raises the price target from $120 to $...

davita-expects-2024-adjusted-eps-of-870-980-est-868
DaVita Expects 2024 Adjusted EPS Of $8.70-...
02/13/2024 21:44:41

davita-q4-earnings-insights
DaVita: Q4 Earnings Insights
02/13/2024 21:30:15

davita-q4-adj-eps-187-beats-159-estimate-sales-315b-beat-301b-estimate
DaVita Q4 Adj EPS $1.87 Beats $1.59 Estima...
02/13/2024 21:13:00

DaVita (NYSE:DVA) reported quarterly earnings of $1.87 per share which beat the analyst consensus estimate of $1.59 by 17.61 pe...

earnings-scheduled-for-february-13-2024
Earnings Scheduled For February 13, 2024
02/13/2024 10:05:59

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on reven...

davita-earnings-preview
DaVita Earnings Preview
02/12/2024 15:01:53

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION